In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround ...

A broad range of nanomedicines is being developed to improve drug delivery for CNS disorders. The structure of the blood-brain barrier (BBB), the presence of efflux pumps and the expression of ...

Sea's pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated ...

Abuse or misuse of illegal GHB alone or with other CNS depressants (drugs that cause changes in alertness or consciousness) have caused serious side effects. These effects include seizures ...

Company has one year of cash to fund operations Company advancing plans to develop TPI 287, a novel, late stage abeotaxane ...

An affidavit obtained by the American-Statesman reveals more details about the 17-car crash and the man accused of causing it.

CNS depressants are a broad category of drug such as sedatives that depress the central nervous system. "The driver's vital signs were all in normal range, and he seemed very calm and relaxed ...